Badi Edmond El Osta, Jennifer W. Carlisle, Conor Ernst Steuer, Manali Rupji, Zhengjia Chen, Yuan Liu, Taofeek Kunle Owonikoko, Suresh S. Ramalingam, Ticiana Leal. "A phase 2 study of docetaxel (D), ramucirumab (R), and pembrolizumab (P) for patients with metastatic or recurrent non–small cell lung cancer (NSCLC) who progressed on platinum-doublet and PD-1/PD-L1 blockade.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8594